Prescription medication · Cephalosporin / Beta-Lactamase Inhibitor

ceftazidime/avibactam

Also sold as Avycaz. Avycaz treats complicated infections in the stomach area and urinary tract.

Data updated 2026-05-15

3,178
FDA reports
2
InteractionsFew interactions
Rx
Availability

What the data shows

ceftazidime/avibactam (Avycaz) is a prescription Cephalosporin / Beta-Lactamase Inhibitor, with 3,178 FDA adverse-event reports on file, with 2 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

ceftazidime/avibactam (Avycaz) is a prescription Cephalosporin / Beta-Lactamase Inhibitor. Avycaz treats complicated infections in the stomach area and urinary tract.

Avycaz is a drug that combines two medicines, ceftazidime and avibactam. It fights certain bacterial infections.

Verify with FDA → · CMS NADAC pricing →

View Alternatives → Compare with Another Drug →

What it does

Avycaz treats complicated infections in the stomach area and urinary tract.

Common side effects

Diarrhea, Nausea, Vomiting

Key warnings

Avycaz may cause a lower clinical response in adult patients with complicated intra-abdominal infections and kidney problems.

The sections below are summarized in plain English from ceftazidime/avibactam's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Ceftazidime kills bacteria by attacking their cell walls. Avibactam helps ceftazidime work better by blocking certain enzymes that bacteria use to resist antibiotics. This allows ceftazidime to effectively kill the bacteria.

Side Effects (from patient reports)

Based on 3,178 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for ceftazidime/avibactam, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS)

Serious Warnings

Avycaz may cause a lower clinical response in adult patients with complicated intra-abdominal infections and kidney problems. Your kidney function should be checked daily. The dose of Avycaz may need to be adjusted if you have kidney problems. Avycaz can also cause severe allergic reactions and Clostridium difficile-associated diarrhea (CDAD). Seizures and other nervous system problems can also occur, especially if you have kidney problems.

Known Drug Interactions

moderate probenecid

7 DRUG INTERACTIONS 7.1 Probenecid In vitro , avibactam is a substrate of OAT1 and OAT3 transporters which might contribute to the active uptake from the blood compartment, and thereby its excretion. As a potent OAT inhibitor, probenecid inhibits OAT uptake of avibactam by 56% to 70% in vitro and, therefore, has the potential to decrease the elimination of avibactam when co-administered. Because a clinical interaction study of AVYCAZ or avibactam alone with probenecid has not been conducted, co-administration of AVYCAZ with probenecid is not recommended [ see Clinical Pharmacology ( 12.3 ) ] .

Mechanism: Probenecid blocks the body's ability to move the antibiotic out of the blood and into the urine. This causes the antibiotic levels to stay too high for too long.

minor ceftazidime

7.2 Drug/Laboratory Test Interactions The administration of ceftazidime may result in a false-positive reaction for glucose in the urine with certain methods.

Mechanism: This medicine can interfere with certain lab tests, making it look like there is sugar in your urine when there is not.

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

What should I tell my doctor before taking Avycaz?
Tell your doctor if you are allergic to any medicines, especially cephalosporins, penicillins, or carbapenems. Also, tell them if you have kidney problems, seizures, or a history of diarrhea.
Can Avycaz cause an allergic reaction?
Yes, Avycaz can cause serious allergic reactions, including anaphylaxis. Tell your doctor right away if you have any signs of an allergic reaction, such as rash, hives, swelling, or trouble breathing.
What are the symptoms of Clostridium difficile-associated diarrhea (CDAD)?
Symptoms of CDAD include watery diarrhea, stomach pain, and fever. If you develop these symptoms while taking Avycaz, tell your doctor right away.
Does Avycaz interact with other medications?
Yes, Avycaz can interact with certain medications, such as probenecid. Tell your doctor about all the medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
How long will I need to take Avycaz?
The length of treatment with Avycaz depends on the type and severity of your infection. Your doctor will determine how long you need to take the medication.
What if my kidney function is not normal?
Your doctor will monitor your kidney function and adjust the dose of Avycaz if needed.
Can Avycaz affect lab test results?
Yes, Avycaz may cause a false-positive result for glucose in the urine with certain tests. Make sure your doctor knows you are taking Avycaz before any lab tests.
What if I am breastfeeding?
Talk to your doctor about the risks and benefits of taking Avycaz while breastfeeding.
Can Avycaz cause seizures?
Yes, seizures and other nervous system problems can occur, especially in patients with kidney problems. Tell your doctor if you have a history of seizures.
How is Avycaz given?
Avycaz is given through a needle into your vein (IV) over 2 hours.
What are the common side effects of ceftazidime/avibactam?
The registry lists Diarrhea, Nausea, Vomiting, Rash, Irritation at the injection site among the most-reported FAERS reaction terms for ceftazidime/avibactam. The compiled record contains 3,178 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does ceftazidime/avibactam interact with other medications?
The registry has 2 documented interaction rows for ceftazidime/avibactam. Notable source-record pairings include probenecid, ceftazidime. These rows are not a complete medication review.
What drug class is ceftazidime/avibactam?
ceftazidime/avibactam belongs to the Cephalosporin / Beta-Lactamase Inhibitor drug class. It requires a prescription (Rx). Avycaz treats complicated infections in the stomach area and urinary tract.
What pregnancy or breastfeeding source fields are listed for ceftazidime/avibactam?
The FDA label for ceftazidime/avibactam contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.

Related Medications in Cephalosporin / Beta-Lactamase Inhibitor

Other drugs grouped near ceftazidime/avibactam - same-class peers and common alternatives.

amikacin

Amikin

Amikacin is an antibiotic medicine.

Compare with ceftazidime/avibactam →

amoxicillin

Amoxil

Amoxicillin and Clavulanate Potassium is a combination medicine used to fight bacterial infections.

Compare with ceftazidime/avibactam →

amoxicillin/clavulanate

Augmentin

Augmentin is a combination of two medicines, amoxicillin and clavulanate.

Compare with ceftazidime/avibactam →

ampicillin/sulbactam

Unasyn

Unasyn is a combination of two antibiotics that fights bacteria in your body.

Compare with ceftazidime/avibactam →

azithromycin

Zithromax, Z-Pack

Azithromycin is an antibiotic that fights bacteria.

Compare with ceftazidime/avibactam →

Compare ceftazidime/avibactam vs amikacin side-by-side →

Medication Guides

Understanding Drug Interactions

How CYP450 enzymes, inhibitors, and inducers affect your medications

Generic vs Brand Name Drugs

FDA requirements, cost savings, and when the difference matters

Narrow Therapeutic Index Drugs

FDA bioequivalence and label-record context for narrow therapeutic index medicines

Common Drug Interactions

Dangerous medication combinations and how to protect yourself

Save on ceftazidime/avibactam

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Check Prices on GoodRx →

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for ceftazidime/avibactam

The FDA label for ceftazidime/avibactam (sold under brand names such as Avycaz) classifies it as a prescription-only medication in the Cephalosporin / Beta-Lactamase Inhibitor class. Avycaz treats complicated infections in the stomach area and urinary tract. Official labeling lists 5 commonly reported side effects, including Diarrhea, Nausea, Vomiting.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 3,178 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: April 25, 2025

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Read our methodology - how this data is sourced, computed, and verified.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page